University of California - Irvine Medical Center — Orange, California

Public research footprint of University of California - Irvine Medical Center, compiled from the ClinicalTrials.gov public registry.

305

Registered studies

Active

Recruiting now

170

Completed

Stopped or withdrawn

Most-studied conditions

Acute Respiratory Distress Syndrome (ARDS) · Non Muscle Invasive Bladder Cancer · Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation · Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)

Recently updated registry entries

NCT03767244 — A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced… (Active Not Recruiting)
NCT06532032 — A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With… (Completed)
NCT06701656 — JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of California - Irvine Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.